Skip to main content
Year archive

ORTHOCELL LIMITED — 2024 filings

All 85 regulatory filings released by ORTHOCELL LIMITED (OCC) in 2024, sourced directly from the official regulator.

85 Filings
2024 Period
2024 filings (85)
Filing Released Lang
US FDA Application Submitted for Remplir as US Launch Nears 3 pages 201.1KB
Capital/Financing Update
2024-12-18 English
Major Milestone with First Sales of Remplir in Singapore 3 pages 228.6KB
Capital/Financing Update
2024-12-11 English
Application for quotation of securities - OCC 9 pages 24.0KB
Regulatory Filings
2024-12-09 English
Notification regarding unquoted securities - OCC 10 pages 27.2KB
Share Issue/Capital Change
2024-12-02 English
Application for quotation of securities - OCC 8 pages 20.8KB
Share Issue/Capital Change
2024-12-02 English
Change of Director's Interest Notice-John Van Der Wielen 2 pages 222.4KB
Director's Dealing
2024-12-02 English
Cleansing Notice 1 page 128.2KB
Share Issue/Capital Change
2024-12-02 English
Outstanding Remplir Study Results Pave Way for FDA Clearance 4 pages 268.4KB
Regulatory Filings
2024-12-01 English
Notification regarding unquoted securities - OCC 10 pages 30.6KB
Share Issue/Capital Change
2024-12-01 English
Change of Director's Interest Notice-Paul Anderson 2 pages 225.6KB
Director's Dealing
2024-12-01 English
AGM Addresses by Chair and Managing Director 38 pages 3.8MB
AGM Information
2024-11-28 English
Trading Halt 3 pages 588.1KB
Regulatory Filings
2024-11-28 English
Results of Annual General Meeting 4 pages 209.6KB
Declaration of Voting Results & Voting Rights Announcements
2024-11-28 English
Distributor Signed, Remplir Sales in Singapore to Commence 3 pages 235.3KB
Regulatory Filings
2024-11-26 English
Key Executives Appointed to Drive Remplir US Sales 3 pages 233.2KB
Board/Management Information
2024-11-10 English
Letter, Supp Notice of Meeting & Replacement Proxy Form 14 pages 579.6KB
AGM Information
2024-11-06 English
Orthocell completes $17m Placement 2 pages 183.5KB
Capital/Financing Update
2024-10-30 English
Application for quotation of securities - OCC 8 pages 20.7KB
Share Issue/Capital Change
2024-10-30 English
Cleansing Notice 1 page 128.1KB
Capital/Financing Update
2024-10-30 English
Application for quotation of securities - OCC 9 pages 23.9KB
Share Issue/Capital Change
2024-10-28 English
Notification of cessation of securities - OCC 5 pages 16.2KB
Share Issue/Capital Change
2024-10-28 English
Cleansing Notice 1 page 128.9KB
Regulatory Filings
2024-10-28 English
$17m Placement to Drive Further Growth as US Approval Nears 3 pages 225.5KB
Capital/Financing Update
2024-10-24 English
Proposed issue of securities - OCC 5 pages 18.1KB
Capital/Financing Update
2024-10-24 English
Proposed issue of securities - OCC 5 pages 17.9KB
Capital/Financing Update
2024-10-24 English
Letter to Shareholders, Notice of AGM & Proxy Form 45 pages 928.1KB
AGM Information
2024-10-24 English
Annual Report to Shareholders 65 pages 9.7MB
Annual Report FY 2024
2024-10-24 English
Trading Halt 3 pages 250.4KB
Capital/Financing Update
2024-10-23 English
Quarterly Activity Report & Appendix 4C 9 pages 558.5KB
Interim / Quarterly Report Q1 2025
2024-10-16 English
Application for quotation of securities - OCC 8 pages 21.4KB
Share Issue/Capital Change
2024-10-14 English
Notification of cessation of securities - OCC 5 pages 16.2KB
Share Issue/Capital Change
2024-10-14 English
Cleansing Notice 1 page 128.7KB
Capital/Financing Update
2024-10-14 English
Change of Director's Interest Notice-Paul Anderson 2 pages 224.3KB
Director's Dealing
2024-10-14 English
Regulatory approval to commence Remplir sales in Singapore 3 pages 251.1KB
Regulatory Filings
2024-10-07 English
Second Consecutive Record Quarter as Revenue Exceeds $2m 3 pages 259.3KB
Interim / Quarterly Report Q1 2025
2024-10-06 English
Pause in Trading 1 page 116.6KB
Regulatory Filings
2024-10-06 English
Trading Halt 3 pages 251.3KB
Regulatory Filings
2024-10-06 English
Date of AGM & Closing Date for Director Nominations 1
AGM Information
2024-10-03 English
Notification of cessation of securities - OCC 5 pages 16.3KB
Transaction in Own Shares
2024-09-16 English
Further regarding Company Presentation 2 pages 126.0KB
Investor Presentation
2024-09-10 English
First sales of Striate in major new market of Canada 3 pages 249.8KB
Capital/Financing Update
2024-09-05 English
Company Presentation 33 pages 3.5MB
Investor Presentation
2024-08-29 English
Appendix 4E & Annual Report 67 pages 9.8MB
Annual Report FY 2024
2024-08-29 English
Corporate Governance Statement 13 pages 410.3KB
Governance Information
2024-08-29 English
Appendix 4G 11 pages 358.5KB
Governance Information
2024-08-29 English
Application for quotation of securities - OCC 8 pages 21.3KB
Share Issue/Capital Change
2024-08-07 English
Notification regarding unquoted securities - OCC 8 pages 21.6KB
Share Issue/Capital Change
2024-08-07 English
Striate Expansion Continues with Singapore Application 2 pages 235.0KB
Regulatory Filings
2024-07-28 English
Global Market Expansion Accelerates - New Regions Pending 4 pages 595.0KB
Regulatory Filings
2024-07-23 English
Quarterly Activity Report & Appendix 4C 9 pages 540.7KB
Interim / Quarterly Report Q4 2024
2024-07-15 English
Regulatory Approval to Commence Sales for Striate in Canada 2 pages 237.3KB
Capital/Financing Update
2024-07-10 English
Pause in Trading 1 page 115.1KB
Regulatory Filings
2024-07-09 English
Trading Halt 3 pages 589.3KB
Regulatory Filings
2024-07-09 English
Record Quarterly and Yearly Revenue Show Outstanding Growth 3 pages 265.9KB
Interim / Quarterly Report FY 2024
2024-07-08 English
Notification regarding unquoted securities - OCC 9 pages 25.2KB
Share Issue/Capital Change
2024-06-11 English
Third Revenue Generating Product to be Launched in SmrtGraft 3 pages 302.2KB
Regulatory Filings
2024-06-10 English
Proposed issue of securities - OCC 6 pages 22.2KB
Capital/Financing Update
2024-06-10 English
Notification of cessation of securities - OCC 5 pages 16.8KB
Regulatory Filings
2024-06-04 English
Outstanding 98.6% Success Rate in Striate Implant Study 3 pages 281.3KB
Regulatory Filings
2024-05-13 English
Compelling 85% Success Rate Remplir Study now published 3 pages 261.1KB
Regulatory Filings
2024-04-29 English
Securities Trading Policy 8 pages 314.3KB
Governance Information
2024-04-23 English
Change of Director's Interest Notice-John Van Der Wielen 2 pages 220.4KB
Director's Dealing
2024-04-23 English
Change of Director's Interest Notice-John Van Der Wielen 2 pages 220.4KB
Director's Dealing
2024-04-15 English
Orthocell receives $3.05m R&D tax incentive refund 2 pages 213.5KB
Capital/Financing Update
2024-04-14 English
Quarterly Activity Report & Appendix 4C 9 pages 750.0KB
Interim / Quarterly Report Q3 2024
2024-04-07 English
Part 1 Remplir US Market Authorisation Successfully Complete 3 pages 274.6KB
Regulatory Filings
2024-03-24 English
Application for quotation of securities - OCC 8 pages 21.5KB
Share Issue/Capital Change
2024-03-10 English
Application for quotation of securities - OCC 8 pages 21.4KB
Share Issue/Capital Change
2024-03-10 English
Cleansing Notice 1 page 127.2KB
Share Issue/Capital Change
2024-03-10 English
Application for quotation of securities - OCC 8 pages 20.9KB
Share Issue/Capital Change
2024-02-27 English
Cleansing Notice 1 page 127.6KB
Capital/Financing Update
2024-02-27 English
Appendix 4D & Half-Year Financial Statements 24 pages 6.2MB
Interim / Quarterly Report H1 2024
2024-02-22 English
Strategic Placement to Raise $3.5 million 2 pages 224.5KB
Capital/Financing Update
2024-02-21 English
Proposed issue of securities - OCC 5 pages 17.7KB
Capital/Financing Update
2024-02-21 English
Trading Halt 3 pages 584.5KB
Capital/Financing Update
2024-02-19 English
Remplir Expansion Continues with Singapore Application 2 pages 230.1KB
Capital/Financing Update
2024-02-12 English
Notification of cessation of securities - OCC 5 pages 16.3KB
Share Issue/Capital Change
2024-02-05 English
Quarterly Activity Report & Appendix 4C 10 pages 593.6KB
Interim / Quarterly Report Q2 2024
2024-01-28 English
Notification regarding unquoted securities - OCC 9 pages 33.6KB
Share Issue/Capital Change
2024-01-16 English
Appendix 3Y - Kim Beazley 2 pages 217.1KB
Director's Dealing
2024-01-16 English
Final Director's Interest Notice 2 pages 204.0KB
Director's Dealing
2024-01-15 English
The Hon Kim Beazley AC Joins Orthocell Board 3 pages 203.6KB
Board/Management Information
2024-01-14 English
Proposed issue of securities - OCC 5 pages 28.4KB
Capital/Financing Update
2024-01-14 English
Initial Director's Interest Notice - Mr Kim Beazley 2 pages 182.5KB
Director's Dealing
2024-01-14 English
Orthocell Board Changes 2 pages 199.3KB
Board/Management Information
2024-01-14 English